Heather A. Griffin, Ph.D. - Publications

Affiliations: 
2012 Mathematics University of Arkansas, Little Rock, AR 
Area:
Mathematics, Applied Mathematics

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Yin W, Egawa N, Zheng K, Griffin H, Tian P, Aiyenuro A, Bornstein J, Doorbar J. HPV E6 inhibits E6AP to regulate epithelial homeostasis by modulating keratinocyte differentiation commitment and YAP1 activation. Plos Pathogens. 19: e1011464. PMID 37379354 DOI: 10.1371/journal.ppat.1011464  0.312
2021 Khelil M, Griffin H, Bleeker MCG, Steenbergen RDM, Zheng K, Saunders-Wood T, Samuels S, Rotman J, Vos W, van den Akker BE, de Menezes RX, Kenter GG, Doorbar J, Jordanova ES. Delta-like ligand-Notch1 signalling is selectively modulated by HPV16 E6 to promote squamous cell proliferation and correlates with cervical cancer prognosis. Cancer Research. PMID 33500246 DOI: 10.1158/0008-5472.CAN-20-1996  0.325
2020 Shiraz A, Crawford R, Egawa N, Griffin H, Doorbar J. The Early Detection of Cervical Cancer. The current and changing landscape of cervical disease detection. Cytopathology : Official Journal of the British Society For Clinical Cytology. PMID 32301535 DOI: 10.1111/cyt.12835  0.309
2019 Griffin H, Singh Mudhar H, Rundle P, Shiraz A, Mahmood R, Egawa N, Quint W, Rennie IG, Doorbar J. Human papillomavirus type 16 causes a defined subset of conjunctival in situ squamous cell carcinomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 31485010 DOI: 10.1038/s41379-019-0350-5  0.326
2019 Doorbar J, Griffin H. Refining our understanding of cervical neoplasia and its cellular origins. Papillomavirus Research (Amsterdam, Netherlands). 7: 176-179. PMID 30974183 DOI: 10.1016/j.pvr.2019.04.005  0.303
2019 Hammer A, de Koning MN, Blaakaer J, Steiniche T, Doorbar J, Griffin H, Mejlgaard E, Svanholm H, Quint WG, Gravitt PE. Whole tissue cervical mapping of HPV infection: molecular evidence for focal latent HPV infection in humans. Papillomavirus Research (Amsterdam, Netherlands). PMID 30772498 DOI: 10.1016/j.pvr.2019.02.004  0.316
2018 Stevenson A, Kavanagh K, Pan J, Stevenson L, Griffin H, Doorbar J, Scott E, Deeny M, Cuschieri K, Graham SV. Risk stratification of cervical disease using detection of human papillomavirus (HPV) E4 protein and cellular MCM protein in clinical liquid based cytology samples. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 108: 19-25. PMID 30218891 DOI: 10.1016/j.jcv.2018.08.011  0.313
2015 van Baars R, Griffin H, Wu Z, Soneji YJ, van de Sandt MM, Arora R, van der Marel J, Ter Harmsel B, Jach R, Okon K, Huras H, Jenkins D, Quint WG, Doorbar J. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a. The American Journal of Surgical Pathology. 39: 1518-28. PMID 26379150 DOI: 10.1097/PAS.0000000000000498  0.313
2015 Griffin H, Soneji Y, Van Baars R, Arora R, Jenkins D, van de Sandt M, Wu Z, Quint W, Jach R, Okon K, Huras H, Singer A, Doorbar J. Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 28: 977-93. PMID 25953390 DOI: 10.1038/modpathol.2015.52  0.317
2015 Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I. Human papillomavirus molecular biology and disease association. Reviews in Medical Virology. 25: 2-23. PMID 25752814 DOI: 10.1002/rmv.1822  0.342
2012 Griffin H, Wu Z, Marnane R, Dewar V, Molijn A, Quint W, Van Hoof C, Struyf F, Colau B, Jenkins D, Doorbar J. E4 antibodies facilitate detection and type-assignment of active HPV infection in cervical disease. Plos One. 7: e49974. PMID 23226504 DOI: 10.1371/journal.pone.0049974  0.341
2012 Isaacson Wechsler E, Wang Q, Roberts I, Pagliarulo E, Jackson D, Untersperger C, Coleman N, Griffin H, Doorbar J. Reconstruction of human papillomavirus type 16-mediated early-stage neoplasia implicates E6/E7 deregulation and the loss of contact inhibition in neoplastic progression. Journal of Virology. 86: 6358-64. PMID 22457518 DOI: 10.1128/Jvi.07069-11  0.322
2007 Doorbar J, Griffin H. Intrabody strategies for the treatment of human papillomavirus-associated disease. Expert Opinion On Biological Therapy. 7: 677-89. PMID 17477805 DOI: 10.1517/14712598.7.5.677  0.32
2006 Griffin H, Elston R, Jackson D, Ansell K, Coleman M, Winter G, Doorbar J. Inhibition of papillomavirus protein function in cervical cancer cells by intrabody targeting. Journal of Molecular Biology. 355: 360-78. PMID 16324714 DOI: 10.1016/j.jmb.2005.10.077  0.314
2003 Middleton K, Peh W, Southern S, Griffin H, Sotlar K, Nakahara T, El-Sherif A, Morris L, Seth R, Hibma M, Jenkins D, Lambert P, Coleman N, Doorbar J. Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. Journal of Virology. 77: 10186-201. PMID 12970404 DOI: 10.1128/Jvi.77.19.10186-10201.2003  0.327
Show low-probability matches.